Precision BioSciences Inc... (DTIL)
NASDAQ: DTIL
· Real-Time Price · USD
5.19
0.09 (1.76%)
At close: Jun 05, 2025, 3:59 PM
5.13
-1.16%
After-hours: Jun 05, 2025, 06:55 PM EDT
1.76% (1D)
Bid | 4.75 |
Market Cap | 57.55M |
Revenue (ttm) | 51.14M |
Net Income (ttm) | -21.99M |
EPS (ttm) | -2.87 |
PE Ratio (ttm) | -1.81 |
Forward PE | -1.08 |
Analyst | Buy |
Ask | 5.45 |
Volume | 48,582 |
Avg. Volume (20D) | 136,598 |
Open | 5.18 |
Previous Close | 5.10 |
Day's Range | 5.06 - 5.30 |
52-Week Range | 3.61 - 13.10 |
Beta | 1.47 |
About DTIL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DTIL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DTIL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+23.77%
Precision BioSciences shares are trading higher af...
Unlock content with
Pro Subscription
2 months ago
-11%
Precision BioSciences shares are trading lower following a Q4 EPS miss.

4 weeks ago · businesswire.com
Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapi...